Kali Bromatum Pellet
Product Images NDC 15631-0248

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Kali Bromatum (NDC 15631-0248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Pellets Fda 15631 0248

This is a description for a homeopathic medicine named "Kali Bromatum 1X Eike" used for temporary relief of acne. The product is available in pellet form and contains active and inactive ingredients. The recommended dosage for this product is given for both adults and children, and it is meant to be used for self-limiting conditions. The description also advises that one should seek professional advice before taking this product if pregnant or nursing, and that the product should be kept out of reach of children. The medicine is distributed by Rxhomeo, with manufacturing details provided. The expiration date and other essential information are also given.*

FDA Label Image

Mini Labels Pellets Fda15631 0248

This is a description of a homeopathic product to provide temporary relief for acne. The active ingredient is Kali Bromatum 1x, and the inactive ingredient is Sucrose. It is available in pellet form and is not intended for medical use. The recommended dosage for adults is 4 pellets orally, three times a day or as directed by a physician. Children over 2 years of age should take half the recommended adult dose. The product is identified by the NDC code 15631-0248 and comes with a mini label for select pack sizes.*

FDA Label Image

Rxhomeo Secondary Packing Blister Pack

FDA Label Image

Rxhomeo Secondary Packing Carton Pack

This is a label for a lactose-free homeopathic medicine, manufactured according to the Homoeopathic Pharmacopoeia of the United States (HPUS). The label provides warnings not to use the product for self-limiting conditions and to discontinue use if symptoms worsen or do not improve in four days. It advises those who are pregnant or nursing to seek professional advice before taking it. The medicine is manufactured by Rihomeo Private Limited in India and distributed by Rehomeo, Inc in the USA. The label provides information on packing and distribution, and includes a dosage label on the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.